Synthetic cannabinoids screen with confirmation-12521
Test info
JWH-073
JWH-122
JWH-250
K2
RCS-4
Spice
SYN CANNA UR
Qualitative synthetic cannabinoid analysis includes metabolites of the following:
- AB-CHMINACA
- AB-FUBINACA
- AB-PINACA
- F-AB-PINACA
- ADBICA
- 5F-ADBICA
- ADB-PINACA
- 5F-ADB-PINACA
- AKB-48
- 5Cl-AKB-48
- 5F-AKB-48
- AM2201
- AM694
- BB-22
- BB-22 hydroxyquinolines
- JWH-018
- JWH-073
- JWH-122
- JWH-250
- MAB-CHMINACA
- MAM-2201
- PB-22
- PB-22 hydroxyquinolines
- 5F-PB-22
- 5F-PB-22-hyroxyquinolines
- UR-144
- XLR-11
Positive initial results reflex to additional testing with an additional charge
This test is intended for use in the clinical management of patients. It is not intended for use in employment related testing.
Detection of the use of synthetic cannabinoid drugs
For order by Allina Health facilities and Allina Health contracted clients only
Specimen
Transfer a 10mL (minimum 1.0 mL) aliquot of random urine to a Urine transfer vial/tube (MedTox)
Refrigerated (preferred)
Ambient (OK) - 3 days
Frozen (OK)
- Urines collected with preservative will be rejected
Performance
Screen: Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS) at a testing threshold of 1.0 ng/mL
Confirmation: definitive Liquid Chromatography/Tandem Mass Spectrometry (LC/MS/MS)
Clinical and Interpretive info
Negative
Screening threshold: 1.0 ng/mL